ARCHIVES

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

This article is from The Cancer Letter archive.

Vol. 20 No. 27 | July 8, 1994

Download PDF Visit The Full Archive

Related Articles

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

NCI To require Prompt Publication Of Data Affected By Falsification In Future Grants

April 8, 1994

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001